Orphan Drug Exclusivity and Pediatric Exclusivity
Paper details:
Develop regulatory strategy for Orphan Drug development: Oral Iron Chelator for beta Thalassemia in a region where such disorder is present and a drug would potentially qualify for orphan drug designation. See instructions attached.
